After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. The Tempo system brings ...

Eli Lilly is just weeks away ... diet and increased physical activity. Lilly decided to hold off on the launch of the drug in GB until Mounjaro KwikPen was cleared for marketing.

That's because Eli Lilly for years has used that device for insulin, so the company can tap into existing manufacturing resources to make more of other incretin drugs. KwikPen is a single four ...